自身免疫性肝炎诊断和治疗共识(2015)

被引:238
作者
Chinese Society of Hepatology
Chinese Medical Association
Chinese Society of Gastroenterology
Chinese Medical Association
Chinese Society of Infectious Diseases
Chinese Medical Association
机构
[1] 中华医学会肝病学分会
[2] 中华医学会消化病学分会
[3] 中华医学会感染病学分会
关键词
肝炎,自身免疫性; 诊断; 治疗; 共识;
D O I
暂无
中图分类号
R575.1 [肝炎];
学科分类号
100201 [内科学];
摘要
<正>1概述自身免疫性肝炎(AIH)是一种由针对肝细胞的自身免疫反应所介导的肝脏实质炎症,以血清自身抗体阳性、高免疫球蛋白G(Ig G)和(或)γ-球蛋白血症、肝组织学上存在界面性肝炎为特点,如不治疗常可导致肝硬化、肝衰竭[1]。AIH的临床表现多样,一般表现为慢性、隐匿起病,但也可表现为急性发作,甚至引起急性肝衰竭。20世纪60至80年代,多项临床研究证实,免疫抑制剂治疗可显著改善AIH患者的生物化学指
引用
收藏
页码:9 / 22
页数:14
相关论文
共 36 条
[1]
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis' [J].
Beuers, Ulrich ;
Gershwin, M. Eric ;
Gish, Robert G. ;
Invernizzi, Pietro ;
Jones, David E. J. ;
Lindor, Keith ;
Ma, Xiong ;
Mackay, Ian R. ;
Pares, Albert ;
Tanaka, Atsushi ;
Vierling, John M. ;
Poupon, Raoul .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (11) :1867-1869
[2]
Autoimmune hepatitis: East meets west [J].
Yang, Fan ;
Wang, Qixia ;
Bian, Zhaolian ;
Ren, Lin-Lin ;
Jia, Jidong ;
Ma, Xiong .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (08) :1230-1236
[3]
Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis [J].
Hartl, Johannes ;
Ehlken, Hanno ;
Weiler-Normann, Christina ;
Sebode, Marcial ;
Kreuels, Benno ;
Pannicke, Nadine ;
Zenouzi, Roman ;
Glaubke, Claudia ;
Lohse, Ansgar W. ;
Schramm, Christoph .
JOURNAL OF HEPATOLOGY, 2015, 62 (03) :642-646
[4]
Unmet clinical need in autoimmune liver diseases [J].
Dyson, Jessica K. ;
Webb, Gwilym ;
Hirschfield, Gideon M. ;
Lohse, Ansgar ;
Beuers, Ulrich ;
Lindor, Keith ;
Jones, David E. J. .
JOURNAL OF HEPATOLOGY, 2015, 62 (01) :208-218
[5]
Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population [J].
Sui, M. ;
Wu, R. ;
Hu, X. ;
Zhang, H. ;
Jiang, J. ;
Yang, Y. ;
Niu, J. .
JOURNAL OF VIRAL HEPATITIS, 2014, 21 (12) :925-929
[6]
Prognosis of acute severe autoimmune hepatitis (AS-AIH): The role of corticosteroids in modifying outcome [J].
Yeoman, Andrew D. ;
Westbrook, Rachel H. ;
Zen, Yoh ;
Bernal, William ;
Al-Chalabi, Thawab ;
Wendon, Julia A. ;
O'Grady, John G. ;
Heneghan, Michael A. .
JOURNAL OF HEPATOLOGY, 2014, 61 (04) :876-882
[7]
IgG4 cholangiopathy – Current concept; diagnosis; and pathogenesis.[J].Kazuichi Okazaki;Kazushige Uchida;Masanori Koyabu;Hideaki Miyoshi;Tsukasa Ikeura;Makoto Takaoka.Journal of Hepatology.2014, 3
[8]
Factors Associated With Response to Therapy and Outcome of Patients With Primary Biliary Cirrhosis With Features of Autoimmune Hepatitis [J].
Ozaslan, Ersan ;
Efe, Cumali ;
Heurgue-Berlot, Alexandra ;
Kav, Taylan ;
Masi, Chiara ;
Purnak, Tugrul ;
Muratori, Luigi ;
Ustundag, Yucel ;
Bresson-Hadni, Solange ;
Thiefin, Gerard ;
Schiano, Thomas D. ;
Wahlin, Staffan ;
Muratori, Paolo .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) :863-869
[9]
The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury.[J].Haiyan Zhang;Yuan Liu;Zhaolian Bian;Shanshan Huang;Xiaofeng Han;Zhengrui You;Qixia Wang;Dekai Qiu;Qi Miao;Yanshen Peng;Xiaoying Li;Pietro Invernizzi;Xiong Ma.Journal of Autoimmunity.2014,
[10]
Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis [J].
Czaja, A. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (04) :385-406